Relmada Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $511 | 852 | 0.60 |
| 2024-12-31 | $8.9k | 17k | 0.52 |
| 2024-09-30 | $123k | 38k | 3.24 |
| 2024-06-30 | $139k | 46k | 3.00 |
| 2024-03-31 | $560k | 121k | 4.65 |
| 2023-12-31 | $373k | 90k | 4.14 |
| 2023-09-30 | $370k | 123k | 3.00 |
| 2023-06-30 | $499k | 203k | 2.46 |
| 2022-12-31 | $1.7M | 489k | 3.50 |
| 2022-06-30 | $5.9M | 315k | 18.69 |
| 2022-03-31 | $7.1M | 266k | 26.81 |
| 2021-06-30 | $854k | 26k | 32.39 |
| 2020-12-31 | $373k | 12k | 32.09 |
| 2020-09-30 | $505k | 13k | 37.56 |
| 2020-06-30 | $2.0M | 46k | 44.67 |
| 2020-03-31 | $26k | 776 | 33.51 |
| 2019-12-31 | $263k | 6.7k | 38.92 |